The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease
Abstract
Progressive loss of dopaminergic neurons in the substantia nigra pars compacta and their terminal connections in the striatum are central features in Parkinson’s disease (PD). Emerging evidence supports the notion that microglia neuroinflammatory responses speed neurodegenerative events. We demonstrated previously that this can be slowed by adoptive transfer of T cells from Copolymer-1-immunized mice administered to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) recipients. The cellular basis for this neuroprotective response was the CD4+ T cell population, suggesting involvement of CD4+CD25+ regulatory T cells (Tregs), cells known to suppress immune activation and maintain immune homeostasis and tolerance. We show for the first time that adoptive transfer of CD3-activated Tregs to MPTP-intoxicated mice provides greater than 90% protection of the nigrostriatal system. The response was dose-dependent and paralleled modulation of microglial responses and up-regulation of glial cell-derived neurotrophic factor (CDNF) and TGF-β. Interestingly, that adoptive transfer of effector T cells showed no significant neuroprotective activities. Tregs were found to mediate neuroprotection through suppression of microglial responses to stimuli, including aggregated, nitrated α-synuclein. Moreover, Treg-mediated suppression was also operative following removal of Tregs from culture prior to stimulation. This neuroprotection was achieved through modulation of microglial oxidative stress and inflammation. As Tregs can be modulated in vivo, these data strongly support the use of such immunomodulatory strategies to treat PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Nakamura, K., Kitani, A., & Strober, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.629 · Cited by 1,594
Sakaguchi, S., Sakaguchi, N., Shimizu, J., Yamazaki, S., Sakihama, T., Itoh, M., Kuniyasu, Y., Nomura, T., Toda, M., & Takahashi, T. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820102.x · Cited by 1,505
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · cited 2×
“Previous studies showed that blockade of a ROS response in microglial prevented dopaminergic cytotoxicity in response to N- -syn [44].”
BackgroundSuppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific
Thornton, A. M., & Shevach, E. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.183 · Cited by 1,229
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Hoffmann, P., Ermann, J., Edinger, M., Fathman, C. G., & Strober, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020399 · Cited by 1,098
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 2×
“Of the microglial secretory factors known to influence secondary degeneration, TNF- and iNOS are implicated in stimulating the dopaminergic cell loss observed following MPTP intoxication [21].”
BackgroundButovsky, O., Ziv, Y., Schwartz, A., Landa, G., Talpalar, A. E., Pluchino, S., Martino, G., & Schwartz, M. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.10.006 · Cited by 923
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy
Moalem, G., Leibowitz–Amit, R., Yoles, E., Mor, F., Cohen, I. R., & Schwartz, M. (1999) · Nature Medicine · doi:10.1038/4734 · Cited by 889
Suri-Payer, E., Amar, A. Z., Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1212 · Cited by 860
Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells
Yagi, H., Nomura, T., Nakamura, K., Yamazaki, S., Kitawaki, T., Hori, S., Maeda, M., Onodera, M., Uchiyama, T., Fujii, S., et al. (2004) · International Immunology · doi:10.1093/intimm/dxh165 · Cited by 801
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism
Markey, S. P., Johannessen, J. N., Chiueh, C. C., Burns, R. S., & Herkenham, M. A. (1984) · Nature · doi:10.1038/311464a0 · Cited by 786
Kohm, A. P., Carpentier, P. A., Anger, H. A., & Miller, S. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4712 · Cited by 782
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 660
Diagnosis and treatment of Parkinson disease: molecules to medicine
Savitt, J. M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29178 · Cited by 650
Nonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
Chen, H., Zhang, S. M., Hernán, M. A., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 634
Nakamura, K., Kitani, A., Fuss, I., Pedersen, A., Harada, N., Nawata, H., & Strober, W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.834 · Cited by 630
Jackson-Lewis, V., Jakowec, M., Burke, R. E., & Przedborski, S. (1995) · Neurodegeneration · doi:10.1016/1055-8330(95)90015-2 · Cited by 609
Przedborski, S., Jackson‐Lewis, V., Naini, A. B., Jakowec, M., Petzinger, G., Miller, R., & Akram, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00183.x · Cited by 507
D-β-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease
Tieu, K., Perier, C., Caspersen, C., Teismann, P., Wu, D.-C., Yan, S.-D., Naini, A., Vila, M., Jackson-Lewis, V., Ramasamy, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318797 · Cited by 497
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
Chen, H., Jacobs, E., Schwarzschild, M. A., McCullough, M. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2005) · Annals of Neurology · doi:10.1002/ana.20682 · Cited by 472
Oxidative Stress and the Pathogenesis of Neurodegenerative Disorders
Reynolds, A., Laurie, C., Lee Mosley, R., & Gendelman, H. E. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)82016-2 · Cited by 432
Self-citationEffective treatment of collagen‐induced arthritis by adoptive transfer of CD25+ regulatory T cells
Morgan, M. E., Flierman, R., van Duivenvoorde, L. M., Witteveen, H. J., van Ewijk, W., van Laar, J. M., de vries, R. R. P., & Toes, R. E. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21195 · Cited by 385
The MPTP model of Parkinson's disease
Smeyne, R. J., & Jackson-Lewis, V. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.017 · Cited by 377
Hauben, E., Butovsky, O., Nevo, U., Yoles, E., Moalem, G., Agranov, E., Mor, F., Leibowitz-Amit, R., Pevsner, E., Akselrod, S., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06421.2000 · Cited by 367
A possible role for humoral immunity in the pathogenesis of Parkinson's disease
Orr, C. F., Rowe, D. B., Mizuno, Y., Mori, H., & Halliday, G. M. (2005) · Brain · doi:10.1093/brain/awh625 · Cited by 350
He, Y., Appel, S., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 348
Alterations of T-lymphocyte populations in Parkinson disease
Baba, Y., Kuroiwa, A., Uitti, R. J., Wszolek, Z. K., & Yamada, T. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.07.005 · Cited by 336
Krieglstein, K., Suter-Crazzolara, C., Fischer, W. H., & Unsicker, K. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07052.x · Cited by 324
Bacteria-triggered CD4+ T Regulatory Cells Suppress Helicobacter hepaticus–induced Colitis
Kullberg, M. C., Jankovic, D., Gorelick, P. L., Caspar, P., Letterio, J. J., Cheever, A. W., & Sher, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020556 · Cited by 322
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
Benner, E. J., Mosley, R. L., Destache, C. J., Lewis, T. B., Jackson-Lewis, V., Gorantla, S., Nemachek, C., Green, S. R., Przedborski, S., & Gendelman, H. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400569101 · Cited by 321
Self-citationWang, Y.-H., Ito, T., Wang, Y.-H., Homey, B., Watanabe, N., Martin, R., Barnes, C. J., McIntyre, B. W., Gilliet, M., Kumar, R., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.019 · Cited by 319
Kipnis, J., Yoles, E., Porat, Z., Cohen, A., Mor, F., Sela, M., Cohen, I. R., & Schwartz, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7446 · Cited by 308
Teismann, P., & Ferger, B. (2001) · Synapse · doi:10.1002/1098-2396(200102)39:2<167::aid-syn8>3.0.co;2-u · Cited by 306
CD4+CD25+ Regulatory T Cells Cure Murine Colitis: The Role of IL-10, TGF-β, and CTLA4
Liu, H., Hu, B., Xu, D., & Liew, F. Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5012 · Cited by 293
MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease
Przedborski, S., Tieu, K., Perier, C., & Vila, M. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041771.66775.d5 · Cited by 287
Choi, D.-K., Pennathur, S., Perier, C., Tieu, K., Teismann, P., Wu, D.-C., Jackson-Lewis, V., Vila, M., Vonsattel, J.-P., Heinecke, J. W., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0970-05.2005 · Cited by 282
Członkowska, A., Kohutnicka, M., Kurkowska-Jastrzębska, I., & Członkowski, A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0020 · Cited by 279
Kryczek, I., Wei, S., Zou, L., Zhu, G., Mottram, P., Xu, H., Chen, L., & Zou, W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.40 · Cited by 277
Role of IFN-g in induction of Foxp3 and conversion of CD4+CD25- T cells to CD4+ Tregs
Wang, Z. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25826 · Cited by 274
Cassarino, D. S., Fall, C. P., Swerdlow, R. H., Smith, T. S., Halvorsen, E. M., Miller, S. W., Parks, J. P., Parker, W. D., & Bennett, J. P. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(97)00070-7 · Cited by 265
Hong, J., Li, N., Zhang, X., Zheng, B., & Zhang, J. Z. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502187102 · Cited by 264
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism
Bas, J. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00422-7 · Cited by 250
Louis, E. D., Mayer, S. A., & Rowland, L. P. (2001) · Cited by 243
Vijitruth, R., Liu, M., Choi, D.-Y., Nguyen, X. V., Hunter, R. L., & Bing, G. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-6 · Cited by 236
Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins
Yamada, T., McGeer, P. L., & McGeer, E. G. (1992) · Acta Neuropathologica · doi:10.1007/bf00427222 · Cited by 231
Xu, D., Liu, H., Komai-Koma, M., Campbell, C., McSharry, C., Alexander, J., & Liew, F. Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.394 · Cited by 226
Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2006) · The FASEB Journal · doi:10.1096/fj.05-5106com · Cited by 222
Aharoni, R., Teitelbaum, D., Leitner, O., Meshorer, A., Sela, M., & Arnon, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11472 · Cited by 215
Hauben, E., Agranov, E., Gothilf, A., Nevo, U., Cohen, A., Smirnov, I., Steinman, L., & Schwartz, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12837 · Cited by 208
Beyersdorf, N., Gaupp, S., Balbach, K., Schmidt, J., Toyka, K. V., Lin, C.-H., Hanke, T., Hünig, T., Kerkau, T., & Gold, R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051060 · Cited by 203
Mehlhorn, G., Hollborn, M., & Schliebs, R. (2000) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(00)00012-5 · Cited by 198
Inflammation in Parkinson's disease.
McGeer, P. L., Yasojima, K., & McGeer, E. G. (2001) · PubMed · Cited by 197
Jones, T. B., Basso, D. M., Sodhi, A., Pan, J. Z., Hart, R. P., MacCallum, R. C., Lee, S., Whitacre, C. C., & Popovich, P. G. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02690.2002 · Cited by 188
Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus
Rogove, A. D., & Tsirka, S. E. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70016-8 · Cited by 176
Dual effect of CD4+CD25+regulatory T cells in neurodegeneration: A dialogue with microglia
Kipnis, J., Avidan, H., Caspi, R. R., & Schwartz, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404842101 · Cited by 164
Arimoto, T., Choi, D., Lü, X., Liu, M., Nguyen, X. V., Zheng, N., Stewart, C. A., Kim, H., & Bing, G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.04.011 · Cited by 163
Jones, T. B., Ankeny, D. P., Guan, Z., McGaughy, V. M., Fisher, L. C., Basso, D. M., & Popovich, P. G. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0406-04.2004 · Cited by 149
Yoshimoto, Y., Lin, Q., Collier, T. J., Frim, D. M., Breakefield, X. O., & Bohn, M. C. (1995) · Brain Research · doi:10.1016/0006-8993(95)00596-i · Cited by 146
Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity
Kipnis, J., Yoles, E., Mizrahi, T., Ben-Nur, A., & Schwartz, M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00219-9 · Cited by 141
Giovanni, A., Sieber, B.-A., Heikkila, R. E., & Sonsalla, P. K. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22503-4 · Cited by 140
Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke
Frenkel, D., Huang, Z., Maron, R., Koldzic, D. N., Moskowitz, M. A., & Weiner, H. L. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.022 · Cited by 139
Goudy, K., Burkhardt, B. R., Wasserfall, C. H., Song, S., Campbell‐Thompson, M., Brusko, T. M., Powers, M. A., Clare-Salzler, M. J., Sobel, E. S., Ellis, T. M., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2270 · Cited by 131
Thomas, M. P., Chartrand, K., Reynolds, A. D., Vitvitsky, V., Banerjee, R. V., & Gendelman, H. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04315.x · Cited by 127
Self-citationKim, W.-K., Hwang, S.-Y., Oh, E., Piao, H. Z., Kim, K.-W., & Han, I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7015 · Cited by 125
Kurkowska‐Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-1999-1289 · Cited by 125
Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease
Kurkowska-Jastrzębska, I., Litwin, T., Joniec, I., Ciesielska, A., Przybyłkowski, A., Członkowski, A., & Członkowska, A. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.05.006 · Cited by 117
Liu, B. (2006) · The AAPS Journal · doi:10.1208/aapsj080369 · Cited by 105
Nongenetic causes of Parkinson’s disease
Chade, A., Kasten, M., & Tanner, C. M. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_23 · Cited by 95
Laurie, C. D., Reynolds, A., Coskun, O., Bowman, E., Gendelman, H. E., & Mosley, R. L. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.009 · Cited by 93
Self-citationNeurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases
Dhib-Jalbut, S. S., Arnold, D. L., Cleveland, D. W., Fisher, M., Friedlander, R. M., Mouradian, M. M., Przedborski, S., Trapp, B. D., Wyss‐Coray, T., & Yong, V. W. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.027 · Cited by 91
Neuroprotection by T-cells depends on their subtype and activation state
Wolf, S. A., Fisher, J., Bechmann, I., Steiner, B., Kwidzinski, E., & Nitsch, R. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00367-3 · Cited by 83
Tischner, D. (2006) · Brain · doi:10.1093/brain/awl213 · Cited by 82
Ábrahám, H., & Lázár, G. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02072-2 · Cited by 76
Microglia in Cell Culture and in Transplantation Therapy for Central Nervous System Disease
Dobrenis, K. (1998) · Methods · doi:10.1006/meth.1998.0688 · Cited by 73
Boska, M. D., Lewis, T. B., Destache, C. J., Benner, E. J., Nelson, J. A., Uberti, M., Mosley, R. L., & Gendelman, H. E. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4364-04.2005 · Cited by 72
Self-citationAvidan, H., Kipnis, J., Butovsky, O., Caspi, R. R., & Schwartz, M. (2004) · European Journal of Immunology · doi:10.1002/eji.200424883 · Cited by 70
Sweat function in Parkinson's disease
Mano, Y., Nakamuro, T., Takayanagi, T., & Mayer, R. F. (1994) · Journal of Neurology · doi:10.1007/bf00920619 · Cited by 66
Garção, P., Oliveira, C. R., & Agostinho, P. M. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20870 · Cited by 63
Hirayama, A., Okoshi, Y., Hachiya, Y., Ozawa, Y., Ito, M., Kida, Y., Imai, Y., Kohsaka, S., & Takashima, S. (2001) · PubMed · Cited by 59
Pontoux, C., Banz, A., & Papiernik, M. (2002) · International Immunology · doi:10.1093/intimm/14.2.233 · Cited by 57
Lynch, W. P., Robertson, S. J., & Portis, J. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1408-1419.1995 · Cited by 45
Suzuki, K., Mizuno, Y., & Yoshida, M. (1990) · PubMed · Cited by 38
INFLAMMATION IN PARKINSON'S DISEASE
Benigno, A., Esposito, E., Crescimanno, G., & Di Giovanni, G. (2007) · Nova Science Publishers (Nova Science Publishers, Inc.) · Cited by 24
Clinical Implications of Parkinson's Disease Genetics
Lorincz, M. (2006) · Seminars in Neurology · doi:10.1055/s-2006-951621 · Cited by 15
Tsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Cited by
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation
Matheoud, D., Sugiura, A., Bellemare-Pelletier, A., Laplante, A., Rondeau, C., Chemali, M., Fazel, A., Bergeron, J. J., Trudeau, L.-E., Burelle, Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.039 · Cited by 582
Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation
Uversky, V. N. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04764.x · Cited by 567
Metadata
- Authors
- Reynolds, A. D., Banerjee, R., Liu, J., Gendelman, H. E., & Lee Mosley, R.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-08-03
- Volume
- 82
- Issue
- 5
- Pages
- 1083-1094
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2133759882
- Cited by
- 420
- References
- 91
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.